Zoetis | ZTS - Ativo Circulante





Ativo Circulante Alterar Data
AbbVie USD 37.48B 3.81B 2026-09
Align Technology USD 2.73B 63.03M 2026-09
Bayer EUR 39.6B 5.96B 2026-09
Bristol-Myers Squibb USD 29.77B 1.19B 2026-09
Charles River Laboratories USD 1.54B 5.92M 2026-09
Coherus Biosciences USD 133.79M 72.25M 2026-06
Dentsply International USD 1.98B 50M 2026-09
Eli Lilly USD 65.26B 591M 2026-09
Henry Schein USD 4.78B 176M 2026-09
Idexx Laboratories USD 1.5B 9.48M 2026-09
Illumina USD 3.04B 201M 2026-09
IQVIA Holdings USD 6.45B 225M 2026-09
J&J USD 56.35B 3.42B 2026-09
Laboratory Of America USD 3.97B 151.3M 2026-09
Merck USD 38.94B 2.26B 2026-09
Neogen USD 582.5M 22.1M 2026-06
Pacira USD 10.3B 9.68B 2026-09
Perrigo USD 2.4B 49.7M 2026-09
Pfizer USD 45.01B 3.65B 2026-09
Phibro Animal Health USD 945.17M 9.67M 2026-09
Quest Diagnostics USD 3.12B 273M 2026-09
Sanofi EUR 33.21B 1.68B 2026-09
Sanofi EUR 31.52B 1.36B 2026-06
Zoetis USD 6.29B 63M 2026-09